FDA
-
-
-
-
-
-
-
GSK wins FDA approval for first drug treating liver disease itch
-
-
-
-
-
-
-
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
-
-
-
-
-
-
-
ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain
-
-
-
-
-
-
-
GSK begins shipping influenza vaccine doses for the 2025-26 flu season
-
-
-
-
-
-
-
GSK (GSK): Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease
-
-
-
-
-
-
-
GSK DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages GSK plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GSK
-
-
-
-
-
-
-
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
325,732 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

